Ms. Dixon has 20 years of market access and reimbursement experience in the life science industry. She has previously served as vice president of government affairs and health economics and a member of the senior leadership team at Advanced BioHealing.
Osiris Therapeutics is a stem cell company focused on developing and marketing products to treat conditions in the wound care, orthopedic and sports medicine markets.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
